Related Experiment Video
Updated: Nov 28, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
miR-26 family and its target genes in tumorigenesis and development
Chuangang Li1, Yongyi Li2, Yufeng Lu3
1The Second Affiliated Hospital of Dalian Medical University, Dalian 116027, China.
Abstract:
The microRNA-26 family, including miR-26a, miR-26b, miR-1297 and miR-4465, is a group of broadly conserved small RNAs with identical sequences at the seed region. The expression of miR-26 could be induced by hypoxia via a HIF-dependent mechanism, and up-regulated during multiple cell differentiation. Accumulating studies have demonstrated that miR-26 family members could be detected in many different kinds of tumors, and their validated target genes are involved in cell metabolism, proliferation, differentiation, apoptosis, invasion and metastasis. The expression of miR-26 might be a potentially valuable biomarker and a new target for cancer therapy. In this review, miR-26 family and its target genes in tumorigenesis and development will be summarized as follows.
Insights
The microRNA-26 family, including miR-26a and miR-26b, is linked to cancer development. These microRNAs (miRNAs) may serve as valuable biomarkers and therapeutic targets for various tumors.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The microRNA-26 family (miR-26a, miR-26b, miR-1297, miR-4465) consists of conserved small RNAs with identical seed regions.
- Hypoxia induces miR-26 expression via a HIF-dependent pathway, and it is upregulated during cell differentiation.
Purpose of the Study:
- To review the role of the miR-26 family and its target genes in tumorigenesis and cancer development.
- To summarize the potential of miR-26 as a biomarker and therapeutic target in oncology.
Main Methods:
- Literature review of studies on miR-26 family expression and function in cancer.
- Analysis of validated miR-26 target genes and their involvement in cancer-related processes.
Main Results:
- miR-26 family members are detected in various tumors.
- Validated miR-26 targets are implicated in cell metabolism, proliferation, differentiation, apoptosis, invasion, and metastasis.
Conclusions:
- miR-26 expression is dysregulated in cancer and influences key oncogenic pathways.
- The miR-26 family holds promise as a diagnostic biomarker and a novel therapeutic strategy for cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle

